Literature DB >> 5061305

Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.

J J Wang, D S Chervinsky, J M Rosen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5061305

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  9 in total

1.  Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.

Authors:  Robert S Nickel; Frank Keller; John Bergsagel; Todd Cooper; Marla Daves; Himalee Sabnis; Glen Lew
Journal:  Pediatr Blood Cancer       Date:  2013-12-19       Impact factor: 3.167

2.  Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.

Authors:  A T McGown; T H Ward; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Sphinganine potentiation of cellular differentiation induced by various anti-leukemia drugs in human leukemia cell line HL-60.

Authors:  B Y Yung
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

4.  The mechanism and overcoming of resistance in ACNU-resistant sublines of C6 and 9L rat glioma.

Authors:  T Yoshida; K Shimizu; Y Ushio; T Hayakawa; H Mogami; Y Sakamoto
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

5.  Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin.

Authors:  J H Doroshow; G Y Locker; C E Myers
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

6.  Cytotoxicity of doxorubicin for normal hematopoietic and acute myeloid leukemia cells of the rat.

Authors:  P Sonneveld; J a Mulder; D W van Bekkum
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

7.  Increased uptake of doxorubicin by cells undergoing heat stress does not explain its synergistic cytotoxicity with hyperthermia.

Authors:  Anirudh Sharma; Sanem Özayral; Julia S Caserto; Rosemarie Ten Cate; Nicole M Anders; James D Barnett; Sri Kamal Kandala; Elizabeth Henderson; Jacqueline Stewart; Eleni Liapi; Michelle A Rudek; Nicolaas A P Franken; Arlene L Oei; Preethi Korangath; Fred Bunz; Robert Ivkov
Journal:  Int J Hyperthermia       Date:  2019       Impact factor: 3.914

8.  In vivo tumour-cell proliferation after adriamycin treatment.

Authors:  R Rowley; H A Hopkins; W B Looney
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

9.  Effect of adriamycin on the activities of superoxide dismutase, glutathione peroxidase and catalase in tissues of mice.

Authors:  Y Sazuka; H Tanizawa; Y Takino
Journal:  Jpn J Cancer Res       Date:  1989-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.